Active Vascular Closure Device: The active vascular closure device segment is expected to witness significant growth in the vascular closure devices market. These devices offer advantages such as faster hemostasis and reduced time to ambulation compared to passive vascular closure devices. The demand for active vascular closure devices is increasing due to the rising prevalence of cardiovascular diseases and the growing preference for minimally invasive procedures. Passive Vascular Closure Device: The passive vascular closure device segment is also anticipated to show steady growth in the market. These devices are easy to use and cost-effective, making them a popular choice among healthcare providers. Passive vascular closure devices are commonly used for femoral artery access closure, especially in procedures such as angioplasty and stenting. Access Radial: The radial access segment is gaining traction in the vascular closure devices market due to the increasing adoption of radial artery access for cardiac catheterization procedures. Radial access offers advantages such as lower rates of bleeding complications and faster post-procedure ambulation, driving the demand for vascular closure devices specifically designed for radial access closure. Access Femoral: The femoral access segment remains a key revenue generator in the vascular closure devices market, particularly for procedures such as peripheral vascular interventions and transcatheter aortic valve replacements. Femoral access closure devices play a crucial role in ensuring hemostasis and preventing complications at the femoral puncture site post-procedure. End-use Ambulatory Surgical Centers: Ambulatory surgical centers are witnessing a growing demand for vascular closure devices, as they offer cost-effective outpatient procedures for various cardiovascular interventions. The rise in minimally invasive procedures performed at ambulatory surgical centers is driving the adoption of vascular closure devices to enhance patient comfort and reduce recovery times. End-use Hospitals: Hospitals continue to be the dominant end-user of vascular closure devices, owing to the high volume of cardiovascular procedures performed in hospital settings. The availability of advanced healthcare infrastructure and skilled medical professionals in hospitals further supports the adoption of vascular closure devices for efficient and safe vascular access closure. End-use Others: Other end-use settings, such as specialty clinics and diagnostic centers, are also contributing to the growth of the vascular closure devices market. These facilities are increasingly performing cardiovascular procedures and interventions, leading to a greater demand for reliable vascular closure devices to ensure successful hemostasis and patient safety.